Literature DB >> 29353969

Incidence and mortality of cervical cancer in China, 2013.

Bingbing Song1,2, Chao Ding3, Wangyang Chen1,2, Huixin Sun1,2, Maoxiang Zhang1,2, Wanqing Chen3.   

Abstract

OBJECTIVE: Estimating the incidence and mortality rate of cervical cancer became necessary to establish prevention measures and healthy policies. The aim of this study was to estimate the updated incidence and mortality rate of cervical cancer in 2013 in China.
METHODS: According to the evaluation criteria developed by the National Central Cancer Registry of China, the data submitted from 255 cancer registries met the required standards in 2013. Cervical cancer cases were retrieved from the national database and combined with the 2013 national population data. The age-standardized incidence and mortality rates were based on the demographic structure of the national census 2000 and Segi's world population.
RESULTS: In 2013, the estimated number of new cases and deaths from cervical cancer were 100,700 and 26,400, respectively. The crude incidence of cervical cancer was 15.17/100,000. The age-standardized incidence rates based on the Chinese standard population (ASIRC) and the world standard population (ASIRW) were 11.30/100,000 and 10.30/100,000, respectively. The incidence of cervical cancer in urban areas was 15.62/100,000 and the ASIRC was 11.12/100,000. The incidence of cervical cancer in rural areas was 14.65/100,000 and the ASIRC was 11.47/100,000. The mortality rate of cervical cancer was 3.98/100,000. The age-standardized mortality rates based on the Chinese (ASMRC) and world standard populations (ASMRW) were 2.76/100,000 and 2.62/100,000, respectively. The mortality rate of cervical cancer in urban areas was 3.85/100,000 and in rural areas was 4.14/100,000. Cervical cancer incidence and mortality increased with age. Urban areas had a higher incidence of cervical cancer and lower mortality rates when compared with rural areas.
CONCLUSIONS: Dynamic monitoring of cervical cancer incidence and mortality is the fundamental work of cervical cancer prevention and control. Cervical cancer is a serious issue in women's health, and prevention strategies need to be enhanced, such as human papilloma virus (HPV) vaccination and screening programs.

Entities:  

Keywords:  Cervical cancer; cancer registration; epidemiology

Year:  2017        PMID: 29353969      PMCID: PMC5775020          DOI: 10.21147/j.issn.1000-9604.2017.06.01

Source DB:  PubMed          Journal:  Chin J Cancer Res        ISSN: 1000-9604            Impact factor:   5.087


  25 in total

1.  Cervical cancer.

Authors:  Jayanthi S Lea; Ken Y Lin
Journal:  Obstet Gynecol Clin North Am       Date:  2012-04-24       Impact factor: 2.844

2.  Early estimates of SEER cancer incidence, 2014.

Authors:  Denise Riedel Lewis; Huann-Sheng Chen; Myles G Cockburn; Xiao-Cheng Wu; Antoinette M Stroup; Douglas N Midthune; Zhaohui Zou; Martin F Krapcho; Daniel G Miller; Eric J Feuer
Journal:  Cancer       Date:  2017-02-14       Impact factor: 6.860

3.  Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.

Authors:  J M Walboomers; M V Jacobs; M M Manos; F X Bosch; J A Kummer; K V Shah; P J Snijders; J Peto; C J Meijer; N Muñoz
Journal:  J Pathol       Date:  1999-09       Impact factor: 7.996

4.  The Breast and Cervical Cancer Early Detection Program, Medicaid, and breast cancer outcomes among Ohio's underserved women.

Authors:  Siran M Koroukian; Paul M Bakaki; Phyo Than Htoo; Xiaozhen Han; Mark Schluchter; Cynthia Owusu; Gregory S Cooper; Johnie Rose; Susan A Flocke
Journal:  Cancer       Date:  2017-05-23       Impact factor: 6.860

5.  Education predicts cervical cancer survival: a Lithuanian cohort study.

Authors:  Ieva Vincerževskiene; Domantas Jasilionis; Donatas Austys; Rimantas Stukas; Auguste Kaceniene; Giedre Smailyte
Journal:  Eur J Public Health       Date:  2017-06-01       Impact factor: 3.367

6.  Cancer statistics: updated cancer burden in China.

Authors:  Wanqing Chen
Journal:  Chin J Cancer Res       Date:  2015-02       Impact factor: 5.087

7.  Annual report on status of cancer in China, 2011.

Authors:  Wanqing Chen; Rongshou Zheng; Hongmei Zeng; Siwei Zhang; Jie He
Journal:  Chin J Cancer Res       Date:  2015-02       Impact factor: 5.087

8.  Awareness of cervical cancer and willingness to participate in screening program: Public health policy implications.

Authors:  Somdatta Patra; Madhu Upadhyay; Pragti Chhabra
Journal:  J Cancer Res Ther       Date:  2017 Apr-Jun       Impact factor: 1.805

9.  Cancer incidence and mortality trends in Australian adolescents and young adults, 1982-2007.

Authors:  Fatima A Haggar; David B Preen; Gavin Pereira; Cashel D J Holman; Kristjana Einarsdottir
Journal:  BMC Cancer       Date:  2012-04-20       Impact factor: 4.430

10.  Epidemiology and survival of cervical cancer in the French West-Indies: data from the Martinique Cancer Registry (2002-2011).

Authors:  K Melan; E Janky; J Macni; S Ulric-Gervaise; M-J Dorival; J Veronique-Baudin; C Joachim
Journal:  Glob Health Action       Date:  2017       Impact factor: 2.640

View more
  19 in total

Review 1.  Current issues facing the introduction of human papillomavirus vaccine in China and future prospects.

Authors:  Li Ping Wong; Liyuan Han; Hui Li; Jinshun Zhao; Qinjian Zhao; Gregory D Zimet
Journal:  Hum Vaccin Immunother       Date:  2019-07-16       Impact factor: 3.452

2.  Identification and Experimental Validation of Immune-Associate lncRNAs for Predicting Prognosis in Cervical Cancer.

Authors:  Jing Ye; Xiaojing Chen; Weiguo Lu
Journal:  Onco Targets Ther       Date:  2021-09-07       Impact factor: 4.147

3.  Prevalence and genotype distribution of human papillomavirus among women with cervical lesions in Shenzhen city, China.

Authors:  Qingfeng Mai; Xiaohan Yang; Huan Cheng; Genghang Wu; Zikun Wu
Journal:  Hum Vaccin Immunother       Date:  2020-09-22       Impact factor: 3.452

4.  Suppression of miR-93-5p inhibits high-risk HPV-positive cervical cancer progression via targeting of BTG3.

Authors:  Jie Li; Zhao-Ping Chu; Hua Han; Yuan Zhang; Fei Tian; Jun-Qin Zhang; Xiang-Hua Huang
Journal:  Hum Cell       Date:  2019-01-28       Impact factor: 4.174

Review 5.  Flaming the fight against cancer cells: the role of microRNA-93.

Authors:  Milad Ashrafizadeh; Masoud Najafi; Reza Mohammadinejad; Tahereh Farkhondeh; Saeed Samarghandian
Journal:  Cancer Cell Int       Date:  2020-06-29       Impact factor: 5.722

6.  Trends in Cervical Cancer Mortality in Brazilian Women who are Screened and Not Screened.

Authors:  Adriana Cunha Vargas; Catia Dell Agnolo; Willian Augusto de Melo; Fernando Castilho Pelloso; Lander Dos Santos; Maria Dalva de Barros Carvalho; Sandra Marisa Pelloso
Journal:  Asian Pac J Cancer Prev       Date:  2020-01-01

7.  MicroRNA-217 acts as a tumor suppressor and correlates with the chemoresistance of cervical carcinoma to cisplatin.

Authors:  Zhaojun Yin; Weiru Ren
Journal:  Onco Targets Ther       Date:  2019-01-23       Impact factor: 4.345

8.  Metabolism-Relevant Molecular Classification Identifies Tumor Immune Microenvironment Characterization and Immunotherapeutic Effect in Cervical Cancer.

Authors:  Luyi Li; Hui Gao; Danhan Wang; Hao Jiang; Hongzhu Wang; Jiajian Yu; Xin Jiang; Changjiang Huang
Journal:  Front Mol Biosci       Date:  2021-07-01

9.  Baicalin Inhibits Human Cervical Cancer Cells by Suppressing Protein Kinase C/Signal Transducer and Activator of Transcription (PKC/STAT3) Signaling Pathway.

Authors:  Qianqian Wang; Haiou Xu; Xiaofeng Zhao
Journal:  Med Sci Monit       Date:  2018-04-03

10.  MicroRNA-183-5p Inhibits Aggressiveness of Cervical Cancer Cells by Targeting Integrin Subunit Beta 1 (ITGB1).

Authors:  Wei Zhang; Mingkai Zhang; Lantao Liu; Dan Jin; Pengyu Wang; Jing Hu
Journal:  Med Sci Monit       Date:  2018-10-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.